Innate Pharma - ADR - IPHA - stock price prediction, stock price target, analyst ratings from 3 analysts

Innate Pharma - ADR has a share price target of US$ 8, revenue growth forecast of 323.3%, and profit growth estimate of 96.4% for FY25, based on top 3 analyst calls.